The path to retinoblastoma

Julien Sage () and Michael L. Cleary ()
Additional contact information
Julien Sage: Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California 94305, USA.
Michael L. Cleary: Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California 94305, USA.

Nature, 2012, vol. 481, issue 7381, 269-270

Abstract: Genomic analyses of tumours of the childhood cancer retinoblastoma reveal a low mutation rate, challenging the view that genomic instability is crucial for its progression. The work also identifies a new therapeutic target. See Article p.329

Date: 2012
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/481269a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:481:y:2012:i:7381:d:10.1038_481269a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/481269a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().